UK -Prime Minister Tony Blair has backed David Blunkett in the face of concern over the work and pensions minister's appointment and share investment in DNA Biosciences.
In a press briefing held today, a spokesman for Blair said the PM wanted Blunkett to be allowed to get on with his job.
Blunkett has faced heavy media attention in the wake of the controversy, including calls from the Conservative Party for an investigation.
Shadow leader of the house Chris Grayling said last week: “Mr Blunkett wrote to me today explaining his position in this matter but in doing so left several important questions unanswered. He has failed to deny that discussions are taking place between his department and the company over possible future business.”
DNA Biosciences confirmed that at the time of Blunkett’s appointment to DNA Biosciences as a non-executive director, Blunkett also became a shareholder of the company, but that these shares were transferred on his return to government.
DNA Biosciences said they had not gained any government contracts or received any preferential treatment due to Blunkett’s direct or indirect involvement during his time as a non-executive director, or after he joined government.
This week's edition of Professional Pensions is out now.
Nearly 60% of UK employers consider defined contribution (DC) master trusts to be the "most suitable" pension fund for their employees, according to research by Buck.
Companies which have tried to dodge their pension duties by changing their identities are being "hunted" by The Pensions Regulator (TPR) in a crackdown on non-compliance with auto-enrolment (AE).
Removing liquidity restrictions would enable DC funds to capitalise on the potentially higher and safer returns that DB schemes have benefitted from, says Patrick Marshall.